81 FR 53151 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 155 (August 11, 2016)

Page Range		53151-53151
FR Document		2016-19046

Federal Register, Volume 81 Issue 155 (Thursday, August 11, 2016)

[Federal Register Volume 81, Number 155 (Thursday, August 11, 2016)]
[Notices]
[Page 53151]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-19046]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel; NIAID Peer Review Meeting.
    Date: September 7, 2016.
    Time: 10:00 a.m. to 2:00 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institutes of Health, 3G61, 5601 Fishers Lane, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Travis J. Taylor, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, Room 3G62B, 5601 Fishers Lane, MSC 9823, Bethesda, MD 
20892-9823, (240) 669-5082, [email protected].

 (Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: August 4, 2016.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-19046 Filed 8-10-16; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 81, No. 155 / Thursday, August 11, 2016 / Notices 53151

difficult, the contact person listed above DEPARTMENT OF HEALTH AND The meeting will be closed to the
can provide the information. HUMAN SERVICES public in accordance with the
provisions set forth in sections
III. How To Use the Notice National Institutes of Health 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
This notice lists the OCPM chapters as amended. The contract proposals and
National Institute of Allergy and the discussions could disclose
and subjects published during the Infectious Diseases; Notice of Closed
quarter covered by the notice so the confidential trade secrets or commercial
Meeting property such as patentable material,
reader may determine whether any are
of particular interest. We expect this Pursuant to section 10(d) of the and personal information concerning
notice to be used in concert with future Federal Advisory Committee Act, as individuals associated with the contract
published notices. The OCPM can be amended (5 U.S.C. App.), notice is proposals, the disclosure of which
accessed at http://www.hhs.gov/omha/ hereby given of the following meeting. would constitute a clearly unwarranted
OMHA_Case_Processing_Manual/ The meeting will be closed to the invasion of personal privacy.
index.html. public in accordance with the Name of Committee: National Institute of
provisions set forth in sections Allergy and Infectious Diseases Special
IV. OCPM Releases for March Through 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Emphasis Panel; NIAID Peer Review Meeting.
June 2016 as amended. The grant applications and Date: September 7, 2016.
Time: 10:00 a.m. to 2:00 p.m.
The OCPM is used by OMHA the discussions could disclose
Agenda: To review and evaluate contract
adjudicators and staff to administer the confidential trade secrets or commercial proposals.
OMHA program. It offers day-to-day property such as patentable material, Place: National Institutes of Health, 3G61,
operating instructions, policies, and and personal information concerning 5601 Fishers Lane, Rockville, MD 20892
procedures based on statutes and individuals associated with the grant (Telephone Conference Call).
regulations, and OMHA directives. applications, the disclosure of which Contact Person: Travis J. Taylor, Ph.D.,
would constitute a clearly unwarranted Scientific Review Officer, Scientific Review
The following is a list and description invasion of personal privacy. Program, Division of Extramural Activities,
of new OCPM provisions and the Room 3G62B, 5601 Fishers Lane, MSC 9823,
subject matter. For future quarterly Name of Committee: National Institute of Bethesda, MD 20892–9823, (240) 669–5082,
Allergy and Infectious Diseases Special Travis.Taylor@nih.gov.
notices, we will list only the specific
Emphasis Panel NIAID SBIR Phase II Clinical
updates to the list of manual provisions (Catalogue of Federal Domestic Assistance
Trial Implementation Cooperative Agreement
that have occurred in the covered 3- Program Nos. 93.855, Allergy, Immunology,
(U44).
month period. This information is and Transplantation Research; 93.856,
Date: September 8, 2016.
available on our Web site at http:// Microbiology and Infectious Diseases
Time: 1:00 a.m. to 4:00 p.m.
Research, National Institutes of Health, HHS)
www.hhs.gov/omha/OMHA_Case_ Agenda: To review and evaluate grant
Processing_Manual/index.html. applications. Dated: August 4, 2016.
Place: National Institutes of Health Room Melanie J. Gray,
OCPM Division II: Part A/B Claim 3G31B, 5601 Fishers Lane, Rockville, MD Program Analyst, Office of Federal Advisory
Determinations 20892 (Telephone Conference Call). Committee Policy.
Contact Person: James T. Snyder, Ph.D.,
Chapter 6, Pre-Hearing Case [FR Doc. 2016–19046 Filed 8–10–16; 8:45 am]
Scientific Review Officer Scientific Review
Development. This new chapter Program, Division of Extramural Activities/ BILLING CODE 4140–01–P
describes the pre-hearing case Room 3G31B, National Institutes of Health,
development process for requests for NIAID, 5601 Fishers Lane MSC 9823,
hearing on Medicare Part A and Part B Rockville, MD 20892, (240) 669–5060, DEPARTMENT OF HEALTH AND
james.snyder@nih.gov. HUMAN SERVICES
reconsiderations issued by Qualified
Independent Contractors (QICs) and (Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology, National Institutes of Health
Quality Improvement Organizations
and Transplantation Research; 93.856,
(QIOs), and escalations of requests for Microbiology and Infectious Diseases National Institute of Dental &
reconsideration by a QIC. The pre- Research, National Institutes of Health, HHS) Craniofacial Research; Notice of
hearing case development process helps Closed Meeting
Dated: August 5, 2016.
identify and address evidentiary issues
prior to the hearing to avoid delays and Anna Snouffer, Pursuant to section 10(d) of the
helps to ensure legal requirements Deputy Director, Office of Federal Advisory Federal Advisory Committee Act, as
related to new evidence are observed. Committee Policy. amended (5 U.S.C. App.), notice is
The process also assists staff in [FR Doc. 2016–19045 Filed 8–10–16; 8:45 am] hereby given of the following meeting.
determining whether a hearing is BILLING CODE 4140–01–P The meeting will be closed to the
necessary for a given case. In addition, public in accordance with the
the process guides OMHA staff on provisions set forth in sections
processes available to facilitate the DEPARTMENT OF HEALTH AND 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
hearing process, such as identifying HUMAN SERVICES as amended. The grant applications and
special needs for hearing participants, the discussions could disclose
National Institutes of Health confidential trade secrets or commercial
discovery, using experts, and
property such as patentable material,
sradovich on DSK3GMQ082PROD with NOTICES

conducting pre-hearing conferences. National Institute of Allergy and and personal information concerning
Dated: July 15, 2016. Infectious Diseases; Notice of Closed individuals associated with the grant
Jason M. Green, Meeting applications, the disclosure of which
Chief Advisor, Office of Medicare Hearings Pursuant to section 10(d) of the would constitute a clearly unwarranted
and Appeals. Federal Advisory Committee Act, as invasion of personal privacy.
[FR Doc. 2016–18665 Filed 8–10–16; 8:45 am] amended (5 U.S.C. App.), notice is Name of Committee: National Institute of
BILLING CODE 4152–01–P hereby given of the following meeting. Dental and Craniofacial Research Special

VerDate Sep<11>2014 17:44 Aug 10, 2016 Jkt 238001 PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 E:\FR\FM\11AUN1.SGM 11AUN1

Document Created: 2018-02-09 11:27:29
Document Modified: 2018-02-09 11:27:29

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		September 7, 2016.
FR Citation		81 FR 53151

81 FR 53151 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 155 (August 11, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health